FineMark National Bank & Trust’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-591
Closed -$35K 1014
2016
Q4
$35K Sell
591
-21
-3% -$1.24K ﹤0.01% 706
2016
Q3
$37K Buy
612
+48
+9% +$2.95K ﹤0.01% 677
2016
Q2
$35K Sell
564
-79
-12% -$4.86K ﹤0.01% 700
2016
Q1
$40K Buy
643
+122
+23% +$7.19K ﹤0.01% 634
2015
Q4
$32K Sell
521
-4
-0.8% -$238 ﹤0.01% 719
2015
Q3
$27K Sell
525
-11
-2% -$586 ﹤0.01% 787
2015
Q2
$28K Sell
536
-64
-11% -$3.31K ﹤0.01% 804
2015
Q1
$31K Buy
600
+50
+9% +$2.58K ﹤0.01% 781
2014
Q4
$29K Sell
550
-10
-2% -$509 ﹤0.01% 820
2014
Q3
$26K Buy
560
+31
+6% +$1.46K ﹤0.01% 821
2014
Q2
$25K Buy
529
+75
+17% +$3.49K ﹤0.01% 849
2014
Q1
$21K Sell
454
-110
-20% -$5.09K ﹤0.01% 879
2013
Q4
$27K Sell
564
-304
-35% -$14.2K 0.01% 741
2013
Q3
$38K Buy
868
+178
+26% +$7.59K 0.01% 629
2013
Q2
$29K Buy
+690
New +$28.8K 0.01% 678

Other funds holding XRAY

FineMark National Bank & Trust's XRAY Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Dentsply Sirona (XRAY) in Q1 2017, closing a stake of 591 shares — an estimated $35K sold.

FineMark National Bank & Trust first reported a position in XRAY in Q2 2013 and held it in 15 quarters. The position peaked at $40K in Q1 2016. 553 funds tracked by Wall St. Rank hold XRAY as of Q1 2017.

  • FineMark National Bank & Trust reported no remaining Dentsply Sirona position as of Q1 2017 after selling out during the quarter.
  • FineMark National Bank & Trust sold 591 Dentsply Sirona shares in Q1 2017, an estimated $35K.
  • FineMark National Bank & Trust first reported a position in Dentsply Sirona in Q2 2013 and held it in 15 quarters.
  • FineMark National Bank & Trust's Dentsply Sirona position peaked at $40K in Q1 2016.
  • 553 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.